diabetes approval anticipated later in 2026 Not yet approved in Canada: but worth knowing about now If you've ever wished the GLP-1 medications that have transformed diabetes care could come in a simple daily pill, without needles, refrigeration, or strict timing around meals, you may be closer to that reality than you think
Sig Transduct Target Ther, 2024, Vol 9, (1), p 234
With the arrival of Mounjaro and Wegovy, powered by the blockbuster ingredients tirzepatide and semaglutide, more people are turning to them not just for controlling diabetes but also for shedding extra kilos
never dispose of it in household waste
A natural alternative to GLP-1 drugs could suit people who need intervention, but have either experienced side effects or dont have the means to access pricey drugs